Consensus WalkMe Ltd.

Equities

WKME

IL0011765851

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
7.93 ^USD	+2.06%		+0.89%	-25.68%

Apr. 17	Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating	MT
Apr. 15	Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating	MT

Evolution of the average Target Price on WalkMe Ltd.

Price target over the last 5 years

History of analyst recommendation changes

ecb1d34b1d6c3889ab6f20f9291f.252Im0zqTjp1T8ZgAGrrUVluK3Ml9DkZdg34JyplOxM.ianA7RmuLH1GFbUCTjKfMBc-GQJ1ug1rN0y5XnVWSlGcqs_fCdwIChYbhw~fe99052c2a64990895ef647334e41ec6

Analyst Recommendations on WalkMe Ltd.

Morgan Stanley Trims Price Target on WalkMe to $11 From $12, Keeps Equalweight Rating	Apr. 17	MT
Barclays Adjusts Price Target on WalkMe to $8.50 From $10, Maintains Underweight Rating	Apr. 15	MT
KeyBanc Initiates WalkMe at Sector Weight, Sees Revenue Reacceleration Taking Time, Margin Improvement 'Harder to Come by'	Mar. 21	MT
Wells Fargo Adjusts Price Target on WalkMe to $14 From $12, Maintains Overweight Rating	Feb. 22	MT
Barclays Downgrades WalkMe to Underweight From Equalweight, Sets Price Target at $10	Jan. 12	MT
Morgan Stanley Lifts Price Target on WalkMe to $11 From $10, Keeps Equalweight Rating	Dec. 22	MT
BMO Capital Adjusts WalkMe's Price Target to $11 From $9.50, Keeps Market Perform Rating	Nov. 15	MT
BMO Capital Adjusts Price Target on WalkMe to $9.50 From $10.50, Maintains Market Perform Rating	23-08-14	MT
Barclays Adjusts Price Target on WalkMe to $9 From $10, Maintains Equalweight Rating	23-07-19	MT
Morgan Stanley Adjusts Price Target on WalkMe to $10 From $11, Maintains Equal-Weight Rating	23-05-18	MT
BMO Capital Adjusts Price Target on WalkMe to $10.50 From $11, Maintains Market Perform Rating	23-05-18	MT
Citigroup Adjusts Price Target on WalkMe to $10 From $12, Keeps Neutral Rating	23-05-18	MT
BMO Capital Downgrades WalkMe to Market Perform From Outperform, Adjusts Price Target to $11 From $13	23-05-08	MT
Citigroup Adjusts WalkMe's Price Target to $12 From $11, Maintains Neutral Rating	23-02-17	MT
Goldman Sachs Raises WalkMe's Price Target to $13 From $12, Maintains Buy Rating	23-02-16	MT
BMO Capital Raises WalkMe's Price Target to $13 From $10.50, Maintains Outperform Rating	23-02-16	MT
Wells Fargo Adjusts Price Target on WalkMe to $13 From $12, Maintains Overweight Rating	23-02-16	MT
Morgan Stanley Trims WalkMe's Price Target to $11 From $12, Maintains Equalweight Rating	23-02-16	MT
Citigroup Downgrades WalkMe to Neutral From Buy, Adjusts Price Target to $11 From $12	23-01-12	MT
Citigroup Adjusts WalkMe Price Target to $12 From $15, Maintains Buy Rating	22-11-16	MT
Goldman Sachs Adjusts Price Target on WalkMe to $12 From $16, Maintains Buy Rating	22-11-16	MT
Morgan Stanley Adjusts Price Target on WalkMe to $12 From $13, Maintains Equal-Weight Rating	22-11-16	MT
BMO Capital Trims Price Target on WalkMe to $10.50 From $14, Maintains Outperform Rating	22-11-16	MT
Morgan Stanley Adjusts Price Target on WalkMe to $13 From $14, Maintains Equalweight Rating	22-10-20	MT
Barclays Downgrades WalkMe to Equalweight From Overweight, Adjusts Price Target to $9 From $15	22-10-18	MT